
Color
Founded Year
2014Stage
Series E | AliveTotal Raised
$496.04MValuation
$0000Last Raised
$100M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-19 points in the past 30 days
About Color
Color specializes in genetic testing and health services. It focuses on early detection and management of cancer and hereditary diseases. The company offers genetic screenings to assess the risk for hereditary cancer and heart conditions, as well as services to understand medication responses, aiming to facilitate preventative health measures and personalized care plans. Color primarily serves employers, health plans, unions, and clinicians, providing them with tools to manage the health of their populations. Color was formerly known as Color Global. It was founded in 2014 and is based in Burlingame, California.
Loading...
ESPs containing Color
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The D2C genetic tests market refers to the direct-to-consumer genetic testing category, where individuals can purchase genetic tests without a healthcare provider's involvement. The market promises to provide personalized insights into an individual's genetic makeup, health risks, ancestry, and inherited traits. However, there are concerns about the accuracy and interpretation of results, as well …
Color named as Leader among 9 other companies, including Natera, Ancestry, and Helix.
Color's Products & Differentiators
Behavioral Health
Color’s behavioral health offering is designed to bring high-quality care to more people, where they are, when they need it. Our platform supports public health departments and school districts to reach, screen, and connect more people to care, faster. Including billing management, Medicaid enrollment, and other billing support. We embed in communities we serve, supporting canvassing and awareness-building through schools, libraries and more. We provide frontline staff training and support, including support hotlines. We can help onboard counselors and clinicians in your community or system, improving efficiency from existing teams and access. Real-time reporting on utilization, outcomes, and risks to ensure the right kind of care is reaching your community. HIPAA-compliant platform Color takes security and privacy seriously.
Loading...
Research containing Color
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Color in 3 CB Insights research briefs, most recently on Aug 9, 2023.
Expert Collections containing Color
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Color is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Conference Exhibitors
5,501 items
HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare
Digital Health 50
150 items
The most promising digital health startups transforming the healthcare industry
Digital Health
11,305 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
463 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Color Patents
Color has filed 38 patents.
The 3 most popular patent topics include:
- blindness
- diseases of the eye and adnexa
- monoclonal antibodies

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
9/26/2023 | 9/24/2024 | Grant |
Application Date | 9/26/2023 |
---|---|
Grant Date | 9/24/2024 |
Title | |
Related Topics | |
Status | Grant |
Latest Color News
Mar 5, 2025
Consumer Genomics Market Analysis (2024-2035) Search jobs Market Overview The Consumer Genomics Market has seen remarkable growth in recent years, driven by increasing consumer interest in personalized healthcare, ancestry tracing, and genetic predisposition testing. Consumer genomics refers to the direct-to-consumer (DTC) genetic testing industry, where individuals can access insights about their genetic makeup without requiring a healthcare professional’s prescription. Global Consumer Genomics Market is valued at USD 2.40 Billion in 2022 and is projected to attain a value of USD 10.25 Billion by 2030 at a CAGR of 19.90% during the forecast period, 2022–2028. This market encompasses various product categories, including ancestry DNA testing, health risk assessments, nutrigenomics, pharmacogenomics, and lifestyle-related genetic analysis. The proliferation of affordable and accessible DNA testing kits, along with advancements in sequencing technologies, has made genomic analysis more appealing to consumers. Our comprehensive Consumer Genomics Market report ready with the latest trends, growth opportunities, and strategic analysis- View Sample Report PDF Key applications of consumer genomics include: Ancestry and Genealogy Testing – Helps individuals trace their lineage and heritage. Health and Wellness Genomics – Identifies genetic predispositions to diseases such as diabetes, cancer, and cardiovascular conditions. Nutrigenomics – Provides insights into how genes influence dietary requirements and metabolism. Pharmacogenomics – Determines how individuals respond to medications based on their genetic makeup. Personalized Fitness and Lifestyle – Recommends fitness routines and lifestyle choices based on genetic traits. Regulatory bodies such as the FDA, EMA, and other international health organizations are playing a key role in shaping the market, ensuring data privacy, and maintaining ethical testing standards. The increasing awareness and acceptance of genetic testing for personal use have positioned consumer genomics as a major growth industry over the next decade. Key Market Trends Advancements in Next-Generation Sequencing (NGS) Next-generation sequencing (NGS) has revolutionized genetic testing by reducing the cost and time required for analyzing genetic data. Companies are leveraging NGS to provide more accurate and comprehensive genomic insights to consumers. Growing Consumer Awareness and Demand for Personalized Healthcare With increased health consciousness, more individuals are seeking genetic insights to tailor their healthcare plans. The rise of direct-to-consumer (DTC) testing services has further propelled this trend. Integration of Artificial Intelligence and Big Data Analytics AI and big data analytics are playing a crucial role in analyzing large genomic datasets. Companies are using machine learning algorithms to improve genetic interpretations and provide personalized recommendations. Regulatory Changes and Data Privacy Concerns Governments and regulatory bodies are implementing stringent guidelines on consumer genomic testing to protect consumer data. The enforcement of GDPR and similar laws in other regions has made data privacy a critical concern for market players. Rise of At-Home Genetic Testing Kits The demand for home-based genetic testing kits has surged, particularly after the COVID-19 pandemic, as consumers prefer convenient, non-invasive testing methods. Strategic Partnerships and Mergers Companies are forming alliances with healthcare providers, pharmaceutical firms, and research organizations to enhance product offerings and expand their market reach. Competitive Landscape The consumer genomics market is dominated by several key players, each employing various strategies to maintain a competitive edge. Some of the leading companies include: 23andMe Inc. Color Genomics Inc. Pricing Trends Consumer genomics pricing varies based on test complexity, brand, and service inclusions. While basic ancestry tests range from $50 to $100, more advanced health and wellness tests can cost between $150 and $400. The market is seeing increasing affordability due to competition and technological advancements. Innovations and Developments Blockchain-Based Genomic Data Storage – Enhancing data security and consumer privacy. Epigenetic Testing – Providing insights into how lifestyle factors influence gene expression. Multi-Omics Integration – Combining genomics, proteomics, and metabolomics for a holistic health assessment. Sustainability and Environmental Impact Many companies are adopting sustainable practices, such as biodegradable test kits and ethical sourcing of genetic data. Data privacy laws are also promoting responsible handling of genetic information. Case Studies and Data A case study on 23andMe revealed that their health reports have influenced over 70% of users to make lifestyle changes. Research by Harvard Medical School found that consumer genomic testing has helped detect early signs of chronic diseases in 10% of tested individuals. A survey conducted by MIT Technology Review indicated that 60% of consumers are concerned about genomic data privacy, leading to demand for enhanced security measures. Conclusion and Future Outlook The consumer genomics market is set for exponential growth over the next decade, driven by technological advancements, increasing consumer awareness, and regulatory support. By 2035, the industry is expected to witness greater integration of AI, blockchain, and multi-omics technologies, making genomic insights more accessible and personalized. As ethical considerations and data privacy concerns shape the regulatory landscape, companies must focus on transparency and consumer trust to maintain a competitive advantage. The future of consumer genomics lies in innovation, sustainability, and responsible genomic data usage, opening new avenues for personalized healthcare and preventive medicine. Related Market Insights:
Color Frequently Asked Questions (FAQ)
When was Color founded?
Color was founded in 2014.
Where is Color's headquarters?
Color's headquarters is located at 831 Mitten Road, Burlingame.
What is Color's latest funding round?
Color's latest funding round is Series E.
How much did Color raise?
Color raised a total of $496.04M.
Who are the investors of Color?
Investors of Color include General Catalyst, Emerson Collective, T. Rowe Price, Viking Global Investors, Kindred Ventures and 24 more.
Who are Color's competitors?
Competitors of Color include LetsGetChecked, Human Longevity, Molecular You, NalaGenetics, Geneticure and 7 more.
What products does Color offer?
Color's products include Behavioral Health and 4 more.
Who are Color's customers?
Customers of Color include CDPH, MADPH, CDC and NIH.
Loading...
Compare Color to Competitors
OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.
Everly Health is a digital health platform that specializes in diagnostic-driven care and the healthcare sector. The company offers at-home testing kits and digital tools for diagnosing and managing recurring health conditions, providing results online. Everly Health primarily serves the healthcare ecosystem, including individual consumers and enterprise clients. Everly Health was formerly known as Everly Well. It was founded in 2015 and is based in Austin, Texas.

Genomelink is a personal genomics company that provides deoxyribonucleic acid (DNA) analysis and insights. The company offers a platform for users to upload their raw DNA data to receive a wide range of reports on ancestry, wellness, and personal traits. Genomelink targets individuals interested in exploring their genetic makeup and gaining personalized insights into their health, ancestry, and personal characteristics. It was founded in 2017 and is based in Berkeley, California.

Ancestry operates within the genealogy and genetic testing sectors, offering a platform for individuals to discover and share their family history through a collection of online family history records and deoxyribonucleic acid (DNA) testing services. Ancestry serves individuals seeking to understand their genealogy and connect with their ancestry. It was founded in 1983 and is based in San Francisco, California.
Medical Brain provides a clinical decision support platform focused on healthcare technology. It offers a monitoring system for patients, aggregates and analyzes patient data, and provides insights to both patients and healthcare providers. The platform includes clinical practice modules for various medical conditions, assisting in pre-operative optimization, post-operative recovery, chronic disease management, and preventive care. It was founded in 2017 and is based in New York, New York.
RhythmX AI focuses on providing primary care decision-making through its artificial intelligence (AI) powered precision care platform within the healthcare technology sector. The company offers a suite of tools for physicians, including advanced patient risk stratification, AI-driven care recommendations, and intelligent workflow optimization to deliver hyper-personalized and compassionate care. RhythmX AI primarily serves the healthcare industry, enhancing the capabilities of doctors, hospitals, and healthcare providers with its technology. It was founded in 2023 and is based in Palo Alto, California.
Loading...